TB Control - Narcan Spray Kits

The District of Columbia is seeking proposals for a TB Control contract focused on procuring Narcan Spray Kits, with a specific emphasis on public health intervention strategies. The contract opportunity, identified by the unique ID 66c85b1e829eb5d869072f22, was posted on February 17, 2016, with a proposal submission deadline of February 26, 2016. The primary objective appears to be acquiring Narcan Spray Kits, which are used for emergency opioid overdose reversal, likely as part of a broader public health harm reduction initiative. The procurement seems targeted at healthcare providers, community organizations, and emergency response teams within the District of Columbia who require these critical medical intervention tools. While specific technical requirements are not fully detailed in the provided information, the contract likely requires vendors to demonstrate experience in medical supply distribution, pharmaceutical procurement, and potentially emergency medical supply chain management.

Based on the limited information provided, it is not possible to definitively state specific set-aside designations or enterprise restrictions for this contract opportunity. The brief contract description does not explicitly outline disadvantaged business enterprise (DBE) requirements or participation goals. Similarly, no incumbent vendors or current contractors are identified in the available documentation. The contract appears to be a standard procurement for medical supplies, potentially with a focus on public health emergency response capabilities. Without additional context, the potential award value or budget range cannot be precisely determined. Interested vendors would need to review the full request for proposals (RFP) documentation to understand the complete scope of qualifications, technical specifications, and potential contract value for the Narcan Spray Kits procurement.